Published in Medicine (Baltimore) on October 01, 2014
Sevelamer crystals in the mucosa of the gastrointestinal tract in a teenager with end-stage renal disease. Pediatr Nephrol (2015) 0.88
Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD. Nat Rev Nephrol (2017) 0.75
Elevated serum alkaline phosphatase and cardiovascular or all-cause mortality risk in dialysis patients: A meta-analysis. Sci Rep (2017) 0.75
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis (2003) 16.18
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2009) 12.66
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol (2004) 11.23
Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int (2006) 6.61
Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2008) 4.72
Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res (2006) 3.57
Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int (2005) 3.56
Coronary artery calcification and mortality in diabetic patients with proteinuria. Kidney Int (2010) 3.23
Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol (2009) 2.29
A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States. Kidney Int (2004) 2.29
Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol (2008) 2.05
Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study. Nephrol Dial Transplant (2010) 1.98
Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin J Am Soc Nephrol (2009) 1.95
Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality. Circulation (2009) 1.85
Increased risk of mortality associated with hip fracture in the dialysis population. Am J Kidney Dis (2004) 1.54
Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients. Clin J Am Soc Nephrol (2009) 1.50
Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol (2010) 1.40
Role for alkaline phosphatase as an inducer of vascular calcification in renal failure? Kidney Int (2008) 1.33
Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan dialysis outcomes and practice patterns study. Hemodial Int (2007) 1.26
Pulse wave velocity and vascular calcification at different stages of chronic kidney disease. J Hypertens (2010) 1.21
Vascular calcifications, vertebral fractures and mortality in haemodialysis patients. Nephrol Dial Transplant (2008) 1.14
Bone alkaline phosphatase and mortality in dialysis patients. Clin J Am Soc Nephrol (2011) 1.13
Effects of serum calcium, phosphorous, and intact parathyroid hormone levels on survival in chronic hemodialysis patients in Japan. Ther Apher Dial (2008) 1.06
Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Dis (2010) 1.05
Total hip bone mass predicts survival in chronic hemodialysis patients. Kidney Int (2003) 0.98
Dietary phosphorus intake and mortality in moderate chronic kidney disease: NHANES III. Nephrol Dial Transplant (2011) 0.90
Apoptosis may determine the release of skeletal alkaline phosphatase activity from human osteoblast-line cells. Calcif Tissue Int (2001) 0.89
Bone alkaline phosphatase in CKD-mineral bone disorder. Am J Kidney Dis (2013) 0.87
Sleep disturbance in chronic hemodialysis patients: the impact of depression and anemia. Ren Fail (2007) 1.58
Quality of sleep and psychosocial factors for patients undergoing peritoneal dialysis. Perit Dial Int (2007) 1.50
Association between serum aspartate transaminase and homocysteine levels in hemodialysis patients. Am J Kidney Dis (2002) 1.43
Serum uric acid levels show a 'J-shaped' association with all-cause mortality in haemodialysis patients. Nephrol Dial Transplant (2004) 1.33
Endoplasmic reticulum stress implicated in the development of renal fibrosis. Mol Med (2011) 1.09
Hypoxic preconditioning reinforces HIF-alpha-dependent HSP70 signaling to reduce ischemic renal failure-induced renal tubular apoptosis and autophagy. Life Sci (2009) 1.05
Health-related quality of life of hemodialysis patients in Taiwan: a multicenter study. Blood Purif (2004) 1.02
Relationship between periodontal disease and mortality in patients treated with maintenance hemodialysis. Am J Kidney Dis (2010) 1.00
Higher systemic inflammation is associated with poorer sleep quality in stable haemodialysis patients. Nephrol Dial Transplant (2008) 0.99
A possible rare cause of renal failure in streptococcal infection. Nephrol Dial Transplant (2010) 0.96
Association of serum fetuin A with truncal obesity and dyslipidemia in non-diabetic hemodialysis patients. Eur J Endocrinol (2009) 0.95
Safety issues of long-term glucose load in patients on peritoneal dialysis--a 7-year cohort study. PLoS One (2012) 0.95
Lean body mass predicts long-term survival in Chinese patients on peritoneal dialysis. PLoS One (2013) 0.95
Nasal carriage of methicillin-resistant Staphylococcus aureus is associated with higher all-cause mortality in hemodialysis patients. Clin J Am Soc Nephrol (2010) 0.93
Uremic pruritus, dialysis adequacy, and metabolic profiles in hemodialysis patients: a prospective 5-year cohort study. PLoS One (2013) 0.93
Association of uraemic pruritus with inflammation and hepatitis infection in haemodialysis patients. Nephrol Dial Transplant (2008) 0.93
Influence of relative hypoparathyroidism on the responsiveness to recombinant human erythropoietin in hemodialysis patients. Blood Purif (2003) 0.92
Association of low serum fetuin A levels with poor arteriovenous access patency in patients undergoing maintenance hemodialysis. Am J Kidney Dis (2010) 0.92
Microalbuminuria screening for detecting chronic kidney disease in the general population: a systematic review. Ren Fail (2013) 0.91
High peritoneal KT/V and peritonitis rates are associated with peritoneal calcification. PLoS One (2013) 0.90
Cognitive-behavioral therapy for sleep disturbance decreases inflammatory cytokines and oxidative stress in hemodialysis patients. Kidney Int (2011) 0.90
Rosiglitazone in diabetes control in hemodialysis patients with and without viral hepatitis infection: effectiveness and side effects. Diabetes Care (2007) 0.89
Risk Factors for Development and Progression of Chronic Kidney Disease: A Systematic Review and Exploratory Meta-Analysis. Medicine (Baltimore) (2016) 0.88
Cognitive-behavioral therapy for sleep disturbance in patients undergoing peritoneal dialysis: a pilot randomized controlled trial. Am J Kidney Dis (2008) 0.87
Interleukin-18 is a strong predictor of hospitalization in haemodialysis patients. Nephrol Dial Transplant (2004) 0.87
Metabolic syndrome and abdominal fat are associated with inflammation, but not with clinical outcomes, in peritoneal dialysis patients. Cardiovasc Diabetol (2013) 0.86
Thoracic kidney and contralateral ureteral duplication--a case report and review of the literature. Nephrol Dial Transplant (2005) 0.86
Periodontal disease is associated with metabolic syndrome in hemodialysis patients. Nephrol Dial Transplant (2011) 0.85
Glycosylated hemoglobin and albumin-corrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients. PLoS One (2013) 0.85
Low serum fetuin A levels and incident stroke in patients with maintenance haemodialysis. Eur J Clin Invest (2013) 0.85
Effect of oral ferric citrate on serum phosphorus in hemodialysis patients: multicenter, randomized, double-blind, placebo-controlled study. J Nephrol (2014) 0.84
Electrolysed-reduced water dialysate improves T-cell damage in end-stage renal disease patients with chronic haemodialysis. Nephrol Dial Transplant (2010) 0.84
Relationship between interdialytic weight gain and nutritional markers in younger and older hemodialysis patients. J Ren Nutr (2008) 0.83
Triglyceride to high-density lipoprotein cholesterol ratio predicts cardiovascular outcomes in prevalent dialysis patients. Medicine (Baltimore) (2015) 0.83
Diltiazem suppresses collagen synthesis and IL-1beta-induced TGF-beta1 production on human peritoneal mesothelial cells. Nephrol Dial Transplant (2006) 0.83
Hemorrhagic stroke in chronic dialysis patients. Ren Fail (2004) 0.82
Quantitative comparison of skin colors in patients with ESRD undergoing different dialysis modalities. Am J Kidney Dis (2006) 0.82
Sexual dysfunction in peritoneal dialysis patients. Am J Nephrol (2007) 0.81
Influence of hepatitis C virus infection on soluble cellular adhesion molecules in hemodialysis patients. Blood Purif (2005) 0.81
Partially hydrolyzed guar gum supplement reduces high-fat diet increased blood lipids and oxidative stress and ameliorates FeCl3-induced acute arterial injury in hamsters. J Biomed Sci (2009) 0.81
Peritoneal thickening is not inevitable in long-term peritoneal dialysis and is associated with peritoneal transport characteristics: a two-centre sonographic study. Nephrol Dial Transplant (2007) 0.80
Decreased high-density lipoprotein cholesterol is associated with inflammation and insulin resistance in non-diabetic haemodialysis patients. Nephrology (Carlton) (2010) 0.80
Low-density lipoprotein cholesterol: association with mortality and hospitalization in hemodialysis patients. Blood Purif (2005) 0.80
Atorvastatin increases erythropoietin-stimulating agent hyporesponsiveness in maintenance hemodialysis patients: role of anti-inflammation effects. Am J Nephrol (2008) 0.80
Serum fetuin A and chemerin levels correlate with hepatic steatosis and regional adiposity in maintenance hemodialysis patients. PLoS One (2012) 0.80
Repetitive progressive thermal preconditioning hinders thrombosis by reinforcing phosphatidylinositol 3-kinase/Akt-dependent heat-shock protein/endothelial nitric oxide synthase signaling. J Vasc Surg (2012) 0.80
Tamoxifen downregulates connective tissue growth factor to ameliorate peritoneal fibrosis. Blood Purif (2011) 0.80
Plasma interleukin-18 levels in chronic renal failure and continuous ambulatory peritoneal dialysis. Blood Purif (2005) 0.79
A triglyceride-raising APOA5 genetic variant is negatively associated with obesity and BMI in the Chinese population. Obesity (Silver Spring) (2010) 0.79
Clinical utility of malnutrition-inflammation score in maintenance hemodialysis patients: focus on identifying the best cut-off point. Am J Nephrol (2008) 0.79